NCT01447485

Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients

A Multicenter, Open-label, Single-dose Study to Evaluate the Pharmacokinetics of Valsartan in Japanese Pediatric Patients 6 to 14 Years of Age

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: Novartis Pharmaceuticals · Industry
• Sex: All
• Age: 6 Years – 14 Years
• Healthy volunteers: Not accepted

Summary

This study will assess the pharmacokinetics and safety following single dose of valsartan in Japanese pediatric patients with hypertension, chronic kidney disease, or nephrotic syndrome.

Conditions

• Hypertension
• Chronic Kidney Disease
• Nephrotic Syndrome

Interventions

Type	Name	Description
DRUG	Valsartan (VAL489)

Timeline

• Start date: 2011-08-01
• Primary completion: 2011-10-01
• Completion: 2011-10-01
• First posted: 2011-10-06
• Last updated: 2020-12-21

Locations

2 sites across 1 country: Japan